BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹29 Cr | ₹22 Cr | ₹16 Cr | ₹15 Cr | ₹17 Cr |
What is the latest Appropriations of BAL PHARMA ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹29 Cr |
| Mar2024 | ₹22 Cr |
| Mar2023 | ₹16 Cr |
| Mar2022 | ₹15 Cr |
| Mar2021 | ₹17 Cr |
How is Appropriations of BAL PHARMA Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹29 Cr | 33.10 | |
| Mar2024 | ₹22 Cr | 36.12 | |
| Mar2023 | ₹16 Cr | 7.24 | |
| Mar2022 | ₹15 Cr | -13.08 | |
| Mar2021 | ₹17 Cr | - | |
Compare Appropriations of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹139.4 Cr | -1.8% | 11.5% | -11.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,993.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -1.8% |
11.5% |
-11.9% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses